摘要
目的评估机器人辅助腹腔镜肝切除术的临床疗效。方法回顾性分析复旦大学附属中山医院2010年3月至2016年12月行机器人辅助腹腔镜肝切除术的142例病人的临床资料。结果原发性肝癌62例,结直肠癌肝转移55例,肝门部胆管癌1例,肝良性病变23例,活体肝移植供体1例。≥3个肝段的大范围肝切除占36.6%,<3个肝段的部分肝切除占63.4%。无中转开腹手术。出血量(119.0±121.8)mL,输血率1.4%。R0切除率100%,围手术期并发症发生率(>GradeⅢ)2.8%,病死率为0。术后住院(5.5±2.2)d。原发性肝癌病人术后1、3、5年总体存活率为97.8%、90.8%、76.2%,结直肠癌肝转移病人术后1、2年总体存活率为97.8%、97.8%。结论对于适宜病例,机器人辅助腹腔镜肝切除治疗肝肿瘤安全可靠,近期及远期疗效良好。
Objective To analyze the perioperative and ontological outcomes of robot-assisted laparoscopic liver resection. Methods The clinical data of 142 cases of liver neoplasm underwent robot-assisted laparoscopic liver resection between March, 2010 and December, 2016 at Zhongshan Hospital, Fudan University were analyzed retrospectively. Results There were 62 cases of primary liver cancer, 55 cases of liver metastasis of eoloreetal cancer （CRLM）, I case of hilar eholangiocareinoma, 23 cases of benign liver disease, and 1 case of living donor hepateetomy. Liver resection was the major resection （i〉3 segments） in 52 eases （36.6%） and was the minor liver resection（〈3 segments） in 90 cases （63.4%）. Conversion rate is 0. Operative blood loss was （119.0 ±121.8）mL, and 2 cases （1.4%） received blood transfusion. The R0 resection rate was 100%. The perioperafive complication incidence （〉 grade ） and mortality were 1.4% and O, respectively. The hospital stay was（5.5± 2.2）days, The 1, 3, 5-year overall survival rates for primary liver cancer were 97.8%, 90.8%76.2%, respectively. The 1, 2-year overall survival rates for CRLM were 97.8% and 97.8%, respectively. Conclusion Robot-assisted laparoscopie liver resection for liver neoplasm is safe and feasible in selected patients, with favorable operative outcome and long-term oncologic results.
出处
《中国实用外科杂志》
CSCD
北大核心
2017年第5期548-551,共4页
Chinese Journal of Practical Surgery
关键词
机器人手术系统
腹腔镜
肝切除术
肝肿瘤
robot surgical system
laparoscopy
hepatectomy
liver neoplasms
